PT
info@cannexpor.com
img
img

Pharma grade
cannabis
products
from
Portugal

scroll down
img
Watch video Stop video
About us

Efficient cannabis cultivation and production in the pharma environment

img

Cannexpor Pharma is an EU-based group of companies with an indoor pharmaceutical facility in Portugal that intends to supply premium quality cannabis products to our partners and to patients worldwide.

Our main goal is to become a reliable partner for our clients in various pharmaceutical markets. That’s why we invest in the quality of our products and focus on establishing the most efficient cultivation and production practices for the pharmaceutical market.

View Portugal 2020 Description

Based in Portugal & Distributed from Germany

Portugal is the center of our project, where we locate our production and R&D facility.

Germany is an EU distribution hub.

Based in
Portugal

EU Distribution

Hub in Germany

OUR PRODUCTS

Products we are going to produce in our GMP facility

img

Cannabis flower

Stability and consistency of our cannabis flower are the core requirements throughout our cultivation cycle. That is why we can assure you that the cannabis genetics we select will not only reach the declared level of cannabinoids, but will also show consistently stable results.
Request more information
img
img

Cannabis extracts
& pure API solutions

Within our GMP we will be able to transform cannabis flower into any desirable form in line with the client’s preferences: it’s either full-spectrum cannabis extract or purified cannabinoids (THC / CBD).
Request more information
img
Our values

Values that drive our strategic development

Team

Our team is the highest value of our company. We try to gather the best specialists with a deep knowledge of worldwide cultivation practices and to combine them with an understanding of the regulatory aspects of the European cannabis market.

Premium quality product

Our company adopted a strategic decision to invest in the best quality cannabis product. That is why we chose indoor cultivation, LED-lightning, and very detailed quality control of every product batch.

Trustworthiness

We are a privately owned company and our reputation is the highest priority for us. That is why all the decisions we make focus on promising something we truly can deliver.
img
Milestones

Our ambitious plans
of production expansion

2018
Establishment of the project
2020
Launch of the R&D facility
2022
Launch of the GMP facility
2024
Further expansion
2028
Further expansion
Team

our team is made of the best experts in the field

img
Valerii Levenstam
Board Director
img
Antonio Vieira
Chief Operating Officer
img
Hanna Hlushchenko
Business Development Director
img
Rita Melo
HR Director
img
Sonia Heleno
Qualified Person
img
Carlos Hamon
Agronomist
img
Vanessa Pereira
GACP responsible
Careers

There’re no vacancies at the moment

But feel free to send us your CV anyway
Apply
←Move →
Feed

What’s
new?

Supply agreement with Sanity Group
22.09.2022

Today we are happy to announce that we have signed a supply agreement with one of the leading German cannabis company – Sanity Group.

The whole next year German patients would be able to consume our TOP cannabis flower strain with the proven historical data of THC content in the range of 26-28%.

We are happy to find such a strong partner within the German market and hope this is just the beginning of long-term cooperation in the future.

Amazing genetics
15.11.2021

We have recently finished the 3rd testing cultivation cycle of our cannabis genetics. Out of 9 cultivars we have started phenotyping, we chose the best 3, which achieved the most impressive results. Our strains show not only an amazing level of THC (up to 28% THC), but also stability and consistency of the results during every cultivation cycle.

We aim to supply the highest-quality cannabis flowers!

We got GACP!
23.09.2021

INFARMED finally gave us the final cultivation permission! After several months of inspections INFARMED issued us the final license that confirms that our R&D facility meet GACP requirements and we are able to test and develop different cannabis genetics to satisfy the needs of our clients.

3 years of hard work and we are here!

GDP in Germany
02.08.2021

We are happy to announce that our German legal entity has obtained GDP certificate, that allows us to distribute medical cannabis products in Germany. That step will also allow us to facilitate importing procedures of medical cannabis from Portugal into Germany.

Go, Germany, go!

Portugal 2020 funding
22.12.2020

We are thrilled to announce that we have obtained 2.8 million of additional investment from Portugal 2020 initiative. Cannexpor Pharma has succeeded to prove that our project is not only economically feasible and promising, but also brings a great value for the economic development of Portugal.

We are happy we are impacting economy of Portugal!

img

subscribe for updates

subscribe
img

Contact us

Our office
iParque, E.M., S.A. Business Center Leonardo Da Vinci Parque Tecnológico de Coimbra | 3040-540 Antanhol – Coimbra
Our production facility
3151-909 Condeixa-a-Nova
Contact us:
info@cannexpor.com
info@cannexpor.com
Copy link Link copied
For job opportunities please send CV to:
hr@cannexpor.com
hr@cannexpor.com
Copy link Link copied

Financed together with

img
img
img